Case report

Case Reports

The Role of Brentuximab Vedotin (BV) as Second-Line Treatment of Refractory Classical Hodgkin Lymphoma (cHL) in the Era of Pandemic COVID-19

Rajabto W, Chandika V, Harahap AS, Ham MF

International Medical Case Reports Journal 2022, 15:269-273

Published Date: 1 June 2022